Snapchat settles to avoid social media addiction trial
"The parties are pleased to have been able to resolve this matter in an amicable manner," parent company Snap and ...
"The parties are pleased to have been able to resolve this matter in an amicable manner," parent company Snap and ...
(MedPage Today) -- SAN FRANCISCO -- Incorporating the recently approved bispecific antibody zanidatamab (Ziihera) into first-line treatment for HER2-positive gastroesophageal ...
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -- dupilumab -- ...
A new scientific finding is the foundation for the first clinical trial in the U.S. to study an experimental drug's ability ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.